Update: 19.12.2023
Last week: 49 week 2023 (04.12.2023 - 10.12.2023)
Last full month: November 2023
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 205 918 | 13.6% | 3.4% | 0.1 | 51 331 828 | 14.5% | 3.3% | 0.1 | 10.1% |
| MoM | 643 704 | -6.1% | 3.1% | 0.1 | 159 660 802 | -4.4% | 3.1% | 0 | -9.1% |
| YTD | 5 203 790 | -43.9% | 2.9% | -2 | 1 299 099 326 | -30.9% | 3.3% | -1.6 | -5.3% |
| MAT | 5 777 452 | -42.9% | 2.9% | -2.1 | 1 440 380 982 | -29.2% | 3.3% | -1.6 | -2.8% |
| DEXALGIN | |||||||||
| WoW | 22 650 | 4.6% | 0.4% | 0 | 11 542 817 | 4.4% | 1.1% | 0 | 4.2% |
| MoM | 86 787 | -15.7% | 0.4% | -0.1 | 44 499 433 | -17.6% | 1.1% | -0.2 | -3.4% |
| YTD | 916 769 | -39.8% | 0.4% | -0.2 | 473 890 983 | -27.8% | 1.1% | -0.6 | 0.7% |
| MAT | 978 890 | -40.5% | 0.4% | -0.3 | 504 305 389 | -28.4% | 1.1% | -0.6 | 1.7% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 68 278 | 1.4% | 41.1% | 1.7 | 39 659 010 | 0.7% | 47.0% | 2 | -2.7% |
| MoM | 301 934 | -0.0% | 40.5% | 0.3 | 174 477 823 | 1.5% | 45.7% | 0.8 | -0.9% |
| YTD | 2 945 838 | -28.6% | 39.6% | -14.3 | 1 743 392 075 | -17.5% | 46.6% | -12.9 | -2.8% |
| MAT | 3 105 633 | -29.9% | 39.6% | -14.7 | 1 838 833 464 | -18.6% | 46.7% | -13.3 | -3.9% |
| ESPUMISAN BABY | |||||||||
| WoW | 26 680 | 0.5% | 35.2% | 0.8 | 24 036 456 | 3.0% | 52.4% | 1.4 | -1.8% |
| MoM | 117 363 | -3.4% | 34.7% | -0.5 | 96 858 204 | 2.9% | 50.3% | 0.5 | -2.1% |
| YTD | 1 132 518 | -16.8% | 32.6% | -5.1 | 860 384 458 | 0.2% | 47.8% | -3 | -3.9% |
| MAT | 1 197 830 | -17.3% | 32.5% | -5.2 | 907 504 058 | -0.3% | 47.7% | -3.2 | -4.0% |
| FASTUM | |||||||||
| WoW | 20 990 | 13.7% | 1.1% | 0.2 | 12 766 363 | 13.9% | 2.7% | 0.4 | -2.5% |
| MoM | 71 482 | -3.7% | 0.8% | 0 | 43 180 154 | -3.4% | 2.1% | 0 | -2.6% |
| YTD | 765 397 | -23.1% | 0.9% | -0.3 | 461 775 449 | -11.3% | 2.2% | -0.3 | 3.6% |
| MAT | 810 763 | -23.8% | 0.9% | -0.3 | 487 683 733 | -11.9% | 2.2% | -0.3 | 3.7% |
| IODOMARIN | |||||||||
| WoW | 81 679 | -0.9% | 25.4% | 0 | 14 579 312 | -1.0% | 10.1% | 0.1 | -0.9% |
| MoM | 348 065 | -1.8% | 25.0% | -0.1 | 62 238 629 | -2.3% | 9.9% | 0 | -1.6% |
| YTD | 3 473 884 | 11.9% | 23.4% | 2.9 | 629 987 080 | 4.1% | 9.4% | 0.3 | -1.8% |
| MAT | 3 663 830 | 10.7% | 23.3% | 2.6 | 664 835 514 | 3.4% | 9.4% | 0.1 | -1.7% |
| LIOTON | |||||||||
| WoW | 18 026 | 3.0% | 2.0% | 0.1 | 21 022 769 | 3.2% | 4.0% | 0.1 | -0.4% |
| MoM | 79 088 | -0.9% | 1.9% | 0 | 93 968 557 | -1.6% | 3.9% | 0.1 | -3.3% |
| YTD | 945 551 | -21.6% | 2.1% | -0.5 | 1 158 983 073 | -7.5% | 4.4% | -0.3 | -3.9% |
| MAT | 991 091 | -22.5% | 2.0% | -0.5 | 1 213 867 280 | -7.8% | 4.4% | -0.3 | -4.0% |
| MEZYM | |||||||||
| WoW | 233 939 | 0.8% | 16.2% | 0.2 | 42 182 590 | 1.3% | 11.9% | 0.1 | -0.6% |
| MoM | 1 032 459 | -1.2% | 16.4% | -1 | 180 415 515 | -0.2% | 11.7% | -1 | 4.8% |
| YTD | 10 769 428 | -35.1% | 17.8% | -8 | 1 772 352 194 | -30.0% | 12.5% | -5.9 | -6.2% |
| MAT | 11 519 630 | -35.8% | 17.9% | -8.2 | 1 883 654 819 | -31.0% | 12.5% | -6.2 | -6.5% |
| MIG 400 | |||||||||
| WoW | 156 194 | 1.4% | 2.6% | -0.1 | 20 697 206 | 2.6% | 1.9% | 0 | 4.2% |
| MoM | 627 318 | -0.8% | 2.6% | 0.1 | 82 961 720 | -1.0% | 2.0% | 0 | -3.4% |
| YTD | 6 212 476 | -21.9% | 2.5% | -0.7 | 797 290 392 | -15.2% | 1.9% | -0.6 | 0.7% |
| MAT | 6 651 812 | -21.4% | 2.5% | -0.7 | 851 820 836 | -14.7% | 1.9% | -0.6 | 1.7% |
| PROSTAMOL | |||||||||
| WoW | 27 820 | 3.6% | 14.4% | 0.4 | 46 299 884 | 3.6% | 17.5% | 0.8 | 0.7% |
| MoM | 116 991 | 3.4% | 13.8% | 0.2 | 190 353 864 | 1.6% | 16.3% | 0 | 1.8% |
| YTD | 1 082 926 | -26.8% | 13.5% | -5 | 1 685 706 751 | -18.5% | 15.4% | -4.2 | 0.2% |
| MAT | 1 150 774 | -27.6% | 13.5% | -5.2 | 1 781 643 216 | -19.5% | 15.3% | -4.5 | 0.3% |
| RESPERO MYRTOL | |||||||||
| WoW | 45 799 | 19.5% | 8.5% | 0.5 | 24 537 234 | 19.6% | 8.7% | 0.4 | 12.5% |
| MoM | 142 417 | -2.8% | 8.1% | -0.2 | 74 930 120 | -2.5% | 8.4% | -0.2 | -0.6% |
| YTD | 1 116 093 | -6.0% | 7.5% | -0.8 | 602 691 049 | 7.0% | 8.1% | -0.3 | 3.9% |
| MAT | 1 229 895 | -3.6% | 7.6% | -0.7 | 662 738 709 | 10.1% | 8.2% | -0.2 | 5.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 5 203 790 | -43.9% | 2.9% | -2 | 1 299 099 326 | -30.9% | 3.3% | -1.6 | -5.3% |
| DEXALGIN | 916 769 | -39.8% | 0.4% | -0.2 | 473 890 983 | -27.8% | 1.1% | -0.6 | 0.7% |
| ESPUMISAN (ADULTS) | 2 945 838 | -28.6% | 39.6% | -14.3 | 1 743 392 075 | -17.5% | 46.6% | -12.9 | -2.8% |
| ESPUMISAN BABY | 1 132 518 | -16.8% | 32.6% | -5.1 | 860 384 458 | 0.2% | 47.8% | -3 | -3.9% |
| FASTUM | 765 397 | -23.1% | 0.9% | -0.3 | 461 775 449 | -11.3% | 2.2% | -0.3 | 3.6% |
| IODOMARIN | 3 473 884 | 11.9% | 23.4% | 2.9 | 629 987 080 | 4.1% | 9.4% | 0.3 | -1.8% |
| LIOTON | 945 551 | -21.6% | 2.1% | -0.5 | 1 158 983 073 | -7.5% | 4.4% | -0.3 | -3.9% |
| MEZYM | 10 769 428 | -35.1% | 17.8% | -8 | 1 772 352 194 | -30.0% | 12.5% | -5.9 | -6.2% |
| MIG | 6 212 476 | -21.9% | 2.5% | -0.7 | 797 290 392 | -15.2% | 1.9% | -0.6 | 0.7% |
| PROSTAMOL | 1 082 926 | -26.8% | 13.5% | -5 | 1 685 706 751 | -18.5% | 15.4% | -4.2 | 0.2% |
| RESPERO MYRTOL | 1 116 093 | -6.0% | 7.5% | -0.8 | 602 691 049 | 7.0% | 8.1% | -0.3 | 3.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 5 777 452 | -42.9% | 2.9% | -2.1 | 1 440 380 982 | -29.2% | 3.3% | -1.6 | -2.8% |
| DEXALGIN | 978 890 | -40.5% | 0.4% | -0.3 | 504 305 389 | -28.4% | 1.1% | -0.6 | 1.7% |
| ESPUMISAN (ADULTS) | 3 105 633 | -29.9% | 39.6% | -14.7 | 1 838 833 464 | -18.6% | 46.7% | -13.3 | -3.9% |
| ESPUMISAN BABY | 1 197 830 | -17.3% | 32.5% | -5.2 | 907 504 058 | -0.3% | 47.7% | -3.2 | -4.0% |
| FASTUM | 810 763 | -23.8% | 0.9% | -0.3 | 487 683 733 | -11.9% | 2.2% | -0.3 | 3.7% |
| IODOMARIN | 3 663 830 | 10.7% | 23.3% | 2.6 | 664 835 514 | 3.4% | 9.4% | 0.1 | -1.7% |
| LIOTON | 991 091 | -22.5% | 2.0% | -0.5 | 1 213 867 280 | -7.8% | 4.4% | -0.3 | -4.0% |
| MEZYM | 11 519 630 | -35.8% | 17.9% | -8.2 | 1 883 654 819 | -31.0% | 12.5% | -6.2 | -6.5% |
| MIG | 6 651 812 | -21.4% | 2.5% | -0.7 | 851 820 836 | -14.7% | 1.9% | -0.6 | 1.7% |
| PROSTAMOL | 1 150 774 | -27.6% | 13.5% | -5.2 | 1 781 643 216 | -19.5% | 15.3% | -4.5 | 0.3% |
| RESPERO MYRTOL | 1 229 895 | -3.6% | 7.6% | -0.7 | 662 738 709 | 10.1% | 8.2% | -0.2 | 5.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 205 918 | 13.6% | 3.4% | 0.1 | 51 331 828 | 14.5% | 3.3% | 0.1 | 10.1% |
| DEXALGIN | 22 650 | 4.6% | 0.4% | 0 | 11 542 817 | 4.4% | 1.1% | 0 | 4.2% |
| ESPUMISAN (ADULTS) | 68 278 | 1.4% | 41.1% | 1.7 | 39 659 010 | 0.7% | 47.0% | 2 | -2.7% |
| ESPUMISAN BABY | 26 680 | 0.5% | 35.2% | 0.8 | 24 036 456 | 3.0% | 52.4% | 1.4 | -1.8% |
| FASTUM | 20 990 | 13.7% | 1.1% | 0.2 | 12 766 363 | 13.9% | 2.7% | 0.4 | -2.5% |
| IODOMARIN | 81 679 | -0.9% | 25.4% | 0 | 14 579 312 | -1.0% | 10.1% | 0.1 | -0.9% |
| LIOTON | 18 026 | 3.0% | 2.0% | 0.1 | 21 022 769 | 3.2% | 4.0% | 0.1 | -0.4% |
| MEZYM | 233 939 | 0.8% | 16.2% | 0.2 | 42 182 590 | 1.3% | 11.9% | 0.1 | -0.6% |
| MIG | 156 194 | 1.4% | 2.6% | -0.1 | 20 697 206 | 2.6% | 1.9% | 0 | 4.2% |
| PROSTAMOL | 27 820 | 3.6% | 14.4% | 0.4 | 46 299 884 | 3.6% | 17.5% | 0.8 | 0.7% |
| RESPERO MYRTOL | 45 799 | 19.5% | 8.5% | 0.5 | 24 537 234 | 19.6% | 8.7% | 0.4 | 12.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 643 704 | -6.1% | 3.1% | 0.1 | 159 660 802 | -4.4% | 3.1% | 0 | -9.1% |
| DEXALGIN | 86 787 | -15.7% | 0.4% | -0.1 | 44 499 433 | -17.6% | 1.1% | -0.2 | -3.4% |
| ESPUMISAN (ADULTS) | 301 934 | -0.0% | 40.5% | 0.3 | 174 477 823 | 1.5% | 45.7% | 0.8 | -0.9% |
| ESPUMISAN BABY | 117 363 | -3.4% | 34.7% | -0.5 | 96 858 204 | 2.9% | 50.3% | 0.5 | -2.1% |
| FASTUM | 71 482 | -3.7% | 0.8% | 0 | 43 180 154 | -3.4% | 2.1% | 0 | -2.6% |
| IODOMARIN | 348 065 | -1.8% | 25.0% | -0.1 | 62 238 629 | -2.3% | 9.9% | 0 | -1.6% |
| LIOTON | 79 088 | -0.9% | 1.9% | 0 | 93 968 557 | -1.6% | 3.9% | 0.1 | -3.3% |
| MEZYM | 1 032 459 | -1.2% | 16.4% | -1 | 180 415 515 | -0.2% | 11.7% | -1 | 4.8% |
| MIG | 627 318 | -0.8% | 2.6% | 0.1 | 82 961 720 | -1.0% | 2.0% | 0 | -3.4% |
| PROSTAMOL | 116 991 | 3.4% | 13.8% | 0.2 | 190 353 864 | 1.6% | 16.3% | 0 | 1.8% |
| RESPERO MYRTOL | 142 417 | -2.8% | 8.1% | -0.2 | 74 930 120 | -2.5% | 8.4% | -0.2 | -0.6% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS 20000 IU #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS 10000 ED #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs